Ronald H. Coelyn
Founding Managing Partner
Ron is the Founding Partner of The
Coelyn Group which specializes in Healthcare and Life
Sciences. For the past 17 of his 30-year career, he
has been active in these industries as a
senior executive officer and, most recently, as an
executive search consultant (both as a Founder of
this Firm and as a Partner in the prestigious international
executive search firm SpencerStuart). His executive
search consulting practice spans engagements ranging
from Chairman of The Board, Members of The Board of Directors, President & Chief
Executive Officer to a variety of Vice Presidential
and other senior level executive positions.
Ron was previously the President &
Chief Operating Officer of a medical diagnostics company
(therapeutic drug monitoring and instruments) responsible
for sales and marketing, research and development,
regulatory and clinical affairs, quality systems, manufacturing,
finance, etc. He arranged several Private Placement
investment transactions to fund scientific discovery
and development, successfully took the company public
in an Initial Public Offering (IPO) of equity securities,
and later sold the company to a large multinational
Life Sciences firm.
Concurrently, Ron also co-founded two biotechnology companies, both of which went public after the completion of equity financing and were later acquired by larger firms.
He was also Chairman, President &
Chief Executive Officer, and a majority shareholder
of a healthcare information systems company focused
on practice management and electronic medical records
for physician and dental group practices, small hospitals,
clinics, surgical centers and other alternate care delivery
sites. The company grew rapidly under his leadership
and he was instrumental in its subsequent acquisition
by a large computer hardware manufacturer and value-added-reseller
Previously, he was a senior executive
officer for a Fortune 100 financial services company
that grew from $100 million to more than $1.4 billion
in annual revenues over a six-year period. For several
years he was responsible for the company’s international
business operations headquartered in London, England.
He was also a Vice President, Corporate Finance for
a prestigious regional investment-banking firm.
During his career, Ron has completed
more than 40 mergers and acquisitions, numerous private
placements, foreign currency swaps, income tax treaty
arbitrage transactions, strategic partnerships and
IPO's. He has also been a corporate director, shareholder
and founder of companies involved with pharmaceutical
research and development (cancer research, monoclonal antibodies, etc),
medical device instrumentation (analytical instrumentation),
and medical in vitro diagnostics (automated chromosome
Ron was previously Co-Chairman of LINC
(Life Sciences Industry Council) (now The Southern California Biomedical Council (SoCalBio) of Orange County,
California; a member of the Bio Medical Industry Council's
Board of Directors; an Advisory Board Member of the American
Heart Association (Irvine, California); and an associate member of AdvaMed,
previously the Health Industry Manufacturer's Association
(HIMA); a Member of the Board of Intellectual Capital of Gerbsman Partners, LLC., a specialty investment bank and turn-around/crisis management firm; a frequent speaker at the Capital Roundtable; and until recently, a Corporate Director/Member of The Board of Directors and Chairman of the Compensation Committee of Endologix, Inc., a publicly-traded medical device company.
Lynn S. Nishimoto
Lynn is a Co-Founding Partner of The
Coelyn Group and Managing Director of Recruitment.
For the past 12-years, she has led executive search
engagements in several Life Science industry sectors
including medical devices, biotechnology, pharmaceuticals,
medical diagnostics, and healthcare provider services.
Possessing engaging intellectual incisiveness and piercing intelligence, her projects range from Corporate Directors to Presidents
& Chief Executive Officers, to Chief Scientific
Officers and Vice Presidents of various disciplines
such as sales, marketing, finance, clinical and regulatory affairs and quality systems.
Previously, Lynn held various engineering
management and regulatory positions with large, international
corporations and several entrepreneurial high-tech/biotechnology firms.
She was responsible for contract negotiation
and managed the completion of complex multi-million
dollar projects. She also managed regulatory compliance,
including periodic regulatory and quality system audits
by several governmental agencies. Several years later,
she was recruited by a prestigious boutique executive search
consultancy firm that specialized in the recruitment of senior level executives in the engineering and bioengineering space.
In 1990, Lynn was the Founder and Managing
Director of a successful business consulting practice
focused on strategic planning, capital formation and
corporate partnerships with early and developing stage
high-tech and biotech companies. In 1992, she decided
to return to the executive search profession and co-founded
The Coelyn Group. She was a member of LINC (LifeSciences
Industry Council) (now The Southern California Biomedical Council (SoCalBio) of Orange County, California.